Bionano Genomics Inc (NAS:BNGO)
$ 0.9147 0.0107 (1.18%) Market Cap: 63.22 Mil Enterprise Value: 47.58 Mil PE Ratio: 0 PB Ratio: 0.64 GF Score: 46/100

Bionano Genomics Inc Acquire BioDiscovery Inc Call Transcript

Oct 12, 2021 / 12:30PM GMT
Release Date Price: $53.6 (+4.89%)
Operator

Good day and welcome to the Bionano Genomics conference call announcing its acquisition of BioDiscovery. Today's conference is being recorded. At this time, I would like to turn the conference over to Amy Conrad from Investor Relations. Please go ahead.

Amy Conrad

Thank you, Armie, and good morning, everyone. Welcome to the Bionano Genomics conference call where we will be discussing the acquisition of BioDiscovery. Leading the call today is Dr. Erik Holmlin, CEO of Bionano. He is joined by Chris Stewart, CFO of Bionano; Rich Shippy, CBO of Bionano; and Dr. Soheil Shams, CEO of BioDiscovery, who are available for questions.

This morning, Bionano issued a press release announcing the BioDiscovery transaction. A copy of the release can be found on the Investor Relations page of the company's website.

I would like to remind everyone that certain statements made during this conference call may be forward-looking, including statements about Bionano's strategic and commercialization plans, sales pipeline, anticipated benefits or improvements to the Saphyr

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot